- Home
- IMAX vs SNOA Comparison
IMAX vs SNOA Comparison
Compare IMAX & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAX
- SNOA
- Stock Information
- Founded
- IMAX 1967
- SNOA 1999
- Country
- IMAX Canada
- SNOA United States
- Employees
- IMAX N/A
- SNOA N/A
- Industry
- IMAX
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- IMAX
- SNOA Health Care
- Exchange
- IMAX Nasdaq
- SNOA Nasdaq
- Market Cap
- IMAX N/A
- SNOA 6.4M
- IPO Year
- IMAX 1994
- SNOA 2007
- Fundamental
- Price
- IMAX $25.86
- SNOA $3.21
- Analyst Decision
- IMAX Strong Buy
- SNOA
- Analyst Count
- IMAX 11
- SNOA 0
- Target Price
- IMAX $29.64
- SNOA N/A
- AVG Volume (30 Days)
- IMAX 1.3M
- SNOA 3.5M
- Earning Date
- IMAX 04-23-2025
- SNOA 06-16-2025
- Dividend Yield
- IMAX N/A
- SNOA N/A
- EPS Growth
- IMAX N/A
- SNOA N/A
- EPS
- IMAX 0.46
- SNOA N/A
- Revenue
- IMAX $359,752,000.00
- SNOA $13,973,000.00
- Revenue This Year
- IMAX $17.79
- SNOA $23.89
- Revenue Next Year
- IMAX $4.98
- SNOA $25.45
- P/E Ratio
- IMAX $56.00
- SNOA N/A
- Revenue Growth
- IMAX N/A
- SNOA 13.51
- 52 Week Low
- IMAX $14.94
- SNOA $1.75
- 52 Week High
- IMAX $27.77
- SNOA $9.40
- Technical
- Relative Strength Index (RSI)
- IMAX 61.68
- SNOA 52.32
- Support Level
- IMAX $22.54
- SNOA $3.31
- Resistance Level
- IMAX $25.04
- SNOA $4.20
- Average True Range (ATR)
- IMAX 1.12
- SNOA 0.33
- MACD
- IMAX 0.34
- SNOA -0.04
- Stochastic Oscillator
- IMAX 91.12
- SNOA 48.34
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.